ARCHIVES

Ruckdeschel To Direct Nevada Cancer Institute

This article is from The Cancer Letter archive.

Vol. 35 No. 05 | February 6, 2009

Download PDF Visit The Full Archive

Related Articles

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

Gene Expression Analyses Can Guide MDS Treatments

December 30, 2011

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

November 11, 1983

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

FDA News< Regulations To Ease For Advertising Drugs On TV, Radio

September 12, 1997